Bimekizumab in Chinese Patients with Active Non‑Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study
Article full text The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. The above Graphical Abstracts represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
Authors
- Marga Oortgiesen
- Alexander Marten
- 程永静
- Atul A. Deodhar (ORCID: https://orcid.org/0000-0002-2130-1246)
- 吕良敬
- Xenofon Baraliakos (ORCID: https://orcid.org/0000-0002-9475-9362)
- Jieruo Gu (ORCID: https://orcid.org/0000-0002-8785-0600)
- James Cheng-Chung Wei (ORCID: https://orcid.org/0000-0002-1235-0679)
- Tom Vaux
- Huji Xu
- Xiaobing Wang
- Matthew A. Brown
- Qiang Wang
- Adis journals on behalf of
- Shengqian Xu
- Yi Zhao
- Qi Zhu
Publication Details
- Journal
- Figshare
- Published
- 2026-10-26
- DOI
- https://doi.org/10.6084/m9.figshare.32923940
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00